Revised SPC: Toujeo 300 units/ml (insulin glargine) solution for injection in a pre-filled pen

Section 4.8 now advises lipodystrophy and cutaneous amyloidosis may occur at injection site and delay local insulin absorption. Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions.

Source:

electronic Medicines compendium